AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |
Back to Blog
Antech diagnostics logo10/13/2023 "The opportunity to rule in or rule out IBD early, identify possible causes and use evidence-based medicine to help pet owners understand care recommendations-all quickly and cost-effectively-allow us to treat a dog who is suffering faster. "Diagnosing IBD and identifying the underlying cause used to be a lengthy, expensive process that was frustrating for both clinicians and pet owners," said Jennifer Ogeer, BSc., DVM, MSc., MBA, MA, VP Medical Affairs & Commercial Marketing. Monitoring serial biomarker levels over time may help veterinarians evaluate treatment effectiveness and make appropriate treatment adjustments. Veterinarians can use biomarker levels to recommend and explain additional diagnostic recommendations (e.g., diagnostic imaging, GI endoscopy for biopsies) to pet owners to further define their pet's disease and develop effective treatment plans. Biomarker levels to substantiate and aid with diagnosis and support treatment monitoringīiomarker measurements for gliadin sensitivity (similar to gluten sensitivity), bacterial proliferation ( Escherichia coli) and intestinal inflammation allow veterinarians to identify possible causes of a dog's gastrointestinal clinical signs, which could be chronic enteropathy or food sensitivity. The first diagnostic usage can be when a dog has been experiencing symptoms for about 3-7 days but ideally when symptoms persist for a minimum of 3 weeks.Ģ. Two results: "consistent with CE/IBD" or "not consistent with CE/IBD" allow veterinarians to rule in or rule out IBD early and with confidence. Antech's cost-effective improvement to this standard of care offers two levels of clinical insight: However, traditional methods to diagnose IBD are invasive, time-consuming and expensive, leading to treatment delays. Rapid access to proper treatment is critical. Loss of appetite, weight loss and even anorexia can occur. IBD causes a dog's intestines to become inflamed, interfering with its ability to digest and absorb nutrients. A first in veterinary medicine, the new Canine CE-IBD assay facilitates a higher level of care for dogs with GI symptoms, supporting a more rapid return to health. The Canine CE-IBD assay is a non-invasive test that incorporates data from three biomarkers, which provide objective measurements of disease, to allow rapid, accurate diagnosis of "consistent with CE/IBD" or "not consistent with CE/IBD." The use of biomarkers, described in a study published in an ApJournal of Veterinary Internal Medicine (JVIM) article, helps veterinarians ascertain whether inflammatory disease is present, reinforce the need for further diagnostic procedures, develop more personalized treatment plans, and even monitor a dog's response to therapy. ![]() Retrieved 10 August 2017.FOUNTAIN VALLEY, Calif., J/PRNewswire/ - Antech Diagnostics, part of Mars Veterinary Health, announced today that its novel blood test for canine inflammatory bowel disease (IBD), also called canine chronic enteropathy (CCE), is now available. "Mars is buying a pet health company for $9.1 billion". "Camp Bow Wow's new corporate offices in Westminster take dog-friendly to the next level". "The dark side of modern X-ray equipment". ![]() Announces Acquisition of Sound Technologies, Inc". "VCA Antech expands its foray into medical technology by buying Eklin". animal hospital chain VCA for $7.7 billion". "The High-Cost, High-Risk World of Modern Pet Care". "VCA Inc.: Gentle giant or takeover threat?". "Washington state veterinary practice ratifies union contract". VCA CEO Bob Antin remained in his position. announced its intention to purchase VCA for $9.1 billion, operating it as an independent unit within Mars Petcare. In 2014, VCA acquired the dog day care center Camp Bow Wow, which had about 140 franchises in the US and one in Canada and licensed The Barkley Pet Hotel & Day Spa brand in Westlake Village, California from Beverly Hills Pet Hotels, Inc. In July 2009, VCA purchased diagnostic imaging company Eklin Medical Systems, which was combined with Sound Technologies to form Sound/Antech Imaging Services. In October 2004, VCA purchased Sound Technologies, a company which supplied digital radiology and ultrasound equipment to veterinary hospitals. The name is an abbreviation of "Veterinary Centers of America." VCA acquired its first veterinary clinic, West Los Angeles Veterinary Hospital, in 1987. VCA was founded in 1986 by three health care company executives, Neil Tauber and brothers Robert (Bob) and Arthur (Art) Antin. ![]() ![]() Until its acquisition by Mars in 2017, VCA traded on the NASDAQ under the ticker "WOOF". The company is based in Los Angeles, and was founded in 1986. VCA Animal Hospitals, incorporated as VCA, Inc., operates more than 1,000 animal hospitals in the US and Canada.
0 Comments
Read More
Leave a Reply. |